Centene Corporation released its 2024 Annual Report and 2025 Proxy Statement, with a letter from CEO Sarah M. London and Chairman Frederick H. Eppinger. The report highlights 2024 as a capstone year in the company's value creation journey, marked by significant operational milestones despite industry turbulence.
Key achievements in 2024 included substantial improvements in Medicare STAR ratings, positioning the Medicare business on a path to breakeven by 2027. The Individual business delivered solid, profitable growth, pioneering program integrity changes like the 'Agent of Record Lock' policy to reduce fraud, waste, and abuse.
In Medicaid, Centene navigated historic eligibility redeterminations, securing the majority of its business through the end of the decade with impressive RFP wins. Looking to 2025, the company plans to align Medicaid rates with the post-redeterminations book of business, advance Medicare Advantage towards its 2027 breakeven target, and expand into the Individual Coverage Health Reimbursement Arrangement (ICHRA) market. Centene also plans to accelerate AI deployment in provider contracting and analytics to drive efficiency and strengthen value-based care initiatives.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.